Literature DB >> 20227585

Hidradenitis suppurativa markedly decreases quality of life and professional activity.

Łukasz Matusiak, Andrzej Bieniek, Jacek C Szepietowski.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20227585     DOI： 10.1016/j.jaad.2009.09.021

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  43 in total

Review 1.  Hidradenitis Suppurativa: Causes, Features, and Current Treatments.

Authors:  Caroline Vinkel; Simon Francis Thomsen
Journal:  J Clin Aesthet Dermatol       Date:  2018-10-01

2.  Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa.

Authors:  J S Kirby; M Butt; T King
Journal:  Br J Dermatol       Date:  2019-08-27       Impact factor: 9.302

3.  Clinical manifestations and quality of life in hidradenitis suppurativa patients: survey of participants from an internet support group.

Authors:  Isabel Greco Tavora; Gabriela Cabral Bissoli; Hélio Amante Miot; Juliano Vilaverde Schmitt
Journal:  An Bras Dermatol       Date:  2019-07-29       Impact factor: 1.896

4.  The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials.

Authors:  J S Kirby; L Thorlacius; B Villumsen; J R Ingram; A Garg; K B Christensen; M Butt; S Esmann; J Tan; G B E Jemec
Journal:  Br J Dermatol       Date:  2019-12-26       Impact factor: 9.302

5.  Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018.

Authors:  Claudia J Posso-De Los Rios; Akua Sarfo; Mondana Ghias; Raed Alhusayen; Iltefat Hamzavi; Michelle A Lowes; Afsaneh Alavi
Journal:  Exp Dermatol       Date:  2019-04-29       Impact factor: 3.960

6.  Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota.

Authors:  Benjamin G Vazquez; Ali Alikhan; Amy L Weaver; David A Wetter; Mark D Davis
Journal:  J Invest Dermatol       Date:  2012-08-30       Impact factor: 8.551

7.  Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa.

Authors:  Ahmed Nader; Denise Beck; Peter Noertersheuser; David Williams; Nael Mostafa
Journal:  Clin Pharmacokinet       Date:  2017-09       Impact factor: 6.447

8.  Association of Hidradenitis Suppurativa With Body Image.

Authors:  Sylke Schneider-Burrus; Agata Jost; Eva Milena Johanna Peters; Ellen Witte-Haendel; Wolfram Sterry; Robert Sabat
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

9.  Nicastrin haploinsufficiency alters expression of type I interferon-stimulated genes: the relationship to familial hidradenitis suppurativa.

Authors:  L Cao; D J Morales-Heil; E D O Roberson
Journal:  Clin Exp Dermatol       Date:  2019-01-17       Impact factor: 3.470

Review 10.  [Epidemiology, patient quality of life, and treatment costs of hidradenitis suppurativa/acne inversa].

Authors:  N Kirsten; V Frings; G D Nikolakis; D Presser; M Goebeler; C C Zouboulis; M Augustin
Journal:  Hautarzt       Date:  2021-07-05       Impact factor: 0.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.